Leonard T. Heffner

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

Max S. Topp, Nicola Gökbuget, Anthony S. Stein et al. · The Lancet Oncology · 2014 · 1.2K citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +9

Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma

Sagar Lonial, Edmund K. Waller, Paul G. Richardson et al. · Blood · 2005 · 322 citations · Full text

Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma

Nisha S. Joseph, Jonathan L. Kaufman, Madhav V. Dhodapkar et al. · Journal of Clinical Oncology · 2020 · 231 citations · Full text

High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia

Susan O’Brien, Gary J. Schiller, John Lister et al. · Journal of Clinical Oncology · 2012 · 185 citations

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study

Donna Reece, Ute Hegenbart, Vaishali Sanchorawala et al. · Blood · 2011 · 170 citations · Full text